Molecule Details
| InChIKey | NBQIAPVXQDUVTH-DRJZQVMBSA-N |
|---|---|
| Compound Name | (3S,11S,17S,20S,23R,26S,28S)-3-[[(2S)-2-acetamidohexanoyl]amino]-20-[3-(diaminomethylideneamino)propyl]-28-(4-hexyltriazol-1-yl)-17-(1H-indol-3-ylmethyl)-23-(naphthalen-2-ylmethyl)-2,5,13,16,19,22,25-heptaoxo-1,6,12,15,18,21,24-heptazabicyclo[24.3.0]nonacosane-11-carboxamide |
| Canonical SMILES | CCCCCCc1cn([C@H]2C[C@H]3C(=O)N[C@H](Cc4ccc5ccccc5c4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCC(=O)N[C@H](C(N)=O)CCCCNC(=O)C[C@H](NC(=O)[C@H](CCCC)NC(C)=O)C(=O)N3C2)nn1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.46 |
| Source | ChEMBL |
2D Structure
Activity Profile